Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Paul Bisaro
Paul Bisaro
Watson CEO Seeks Brand-Drug Profits in Shift From Copycats
Bloomberg
Thu, 02/9/12 - 11:49 am
Watson
Pharma CEOs
generics
Paul Bisaro
M&A
branded pharma
Pfizer’s Lipitor Plan Might Not Be ‘Worth It,’ Watson CEO Says
Bloomberg
Wed, 01/25/12 - 10:34 am
Pfizer
Lipitor
generics
Pharma CEOs
Watson
Paul Bisaro
Pfizer’s Share of Lipitor Market Will Continue to Fall, Watson CEO Says
Bloomberg
Fri, 01/6/12 - 11:49 am
Watson
generics
Pfizer
Lipitor
Paul Bisaro
Pharma CEOs
Watson’s Bisaro Tells CNBC Generic Lipitor to Be ‘Huge Product’
Bloomberg
Fri, 02/18/11 - 03:20 pm
Watson Pharmaceuticals
Paul Bisaro
generics
Lipitor
Pfizer
Watson CEO Must Answer FTC Subpoena
Pharmalot
Mon, 12/6/10 - 11:22 am
Watson Pharmaceuticals
Pharma CEOs
FTC
pay-for-delay
Paul Bisaro